Navigation Links
Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
Date:2/12/2008

D STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

Year Ended

December 31,

2007 2006

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss) $(191,704) $144,816

Adjustments to reconcile net

income (loss) to net cash

provided by operating activities:

Deferred income tax

expense (benefit) (958) 28,064

Shortfall tax benefits from

stock-based compensation (360) -

Debt exchange expense - 48,122

Depreciation and amortization 141,358 126,531

Amortization of debt issuance

costs 241 493

Write-off of debt issuance costs

associated with convertible

subordinated notes - 13,105

Stock-based compensation expense 46,695 42,807

Gain on extinguishment of debt (5,319) -

Gain on sale of investment (5,791) -

Loss on disposals of property and

equipment 3,346 3,292

Impairment charge - 12,417

Changes in operating assets and

liabilities:

Receivables (601) (63,932)

Inventory (6,023) 22,640


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email: